Colgate-Palmolive triggered stock overview
Colgate-Palmolive (CL) has recently come into focus as investors reassess consumer staples after mixed share performance over the past year, with the stock closing at US$84.34 and longer term returns varying by timeframe.
See our latest analysis for Colgate-Palmolive.
Recent trading has been choppy, with a 1 day share price return of a 2.0% decline and a 30 day share price return of a 5.1% decline. However, year to date the share price return is 8.6% and the 3 year total shareholder return is 19.8%, suggesting that longer term momentum remains more constructive than the latest pullback implies.
If you are comparing Colgate-Palmolive with other opportunities, this could be a good moment to broaden your watchlist and check out 18 top founder-led companies
With Colgate Palmolive trading at US$84.34 against an indicated intrinsic value gap and a discount to the average analyst price target, the key question is whether you are seeing a genuine value opportunity or a market that is already pricing in future growth.
Most Popular Narrative: 12.8% Undervalued
Colgate-Palmolive's most followed narrative places fair value at $96.68, above the last close of $84.34. This frames the current setup as a valuation gap driven by long term execution on its 2030 plan and margin structure.
Continued investments in AI, digital transformation, and omnichannel demand generation are expected to enhance operational efficiency, customer reach, and data-driven marketing, translating into greater sales effectiveness and margin resilience.
The fair value hinges on a specific mix of steady revenue growth, higher profit margins, and a richer earnings multiple than the broader household products group. Want to see exactly how those building blocks come together, and which assumptions carry the most weight in that $96.68 figure?
Result: Fair Value of $96.68 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this narrative can quickly shift if raw material and packaging costs squeeze margins again, or if consumer caution in key markets continues to weigh on volume growth.
Find out about the key risks to this Colgate-Palmolive narrative.
Another View: High P/E Puts The Spotlight On Expectations
While the SWS DCF model points to value, the current P/E of 31.7x is higher than both the estimated fair ratio of 23.6x and peer averages of 22.1x in the US and 17.6x globally. That premium leaves less room for disappointment if the 2030 plan hits bumps along the way.
For a closer look at how this valuation premium stacks up against earnings power and peers, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With both risks and rewards on the table, the story is not one sided. Look through the data yourself and move quickly to form your own view by weighing up the 3 key rewards and 3 important warning signs
Looking for more investment ideas?
If Colgate-Palmolive is on your radar, this is a smart moment to widen the lens, compare alternatives, and spot opportunities you might otherwise miss.
- Target resilience first by assessing companies screened for robust fundamentals and low risk profiles through the 72 resilient stocks with low risk scores.
- Focus on value by reviewing companies that combine quality metrics with appealing pricing using the 58 high quality undervalued stocks.
- Prioritise reliable income by scanning for potential high yield opportunities and payout consistency via the 11 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com